← Leaderboards
Julide T Celebi
Columbia University Health Sciences
$3,838,159
Attributed
$4,487,588
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $670.3K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,487,588 · 7
By mechanism
R01$2,934,229 · 3
R21$772,439 · 2
K08$619,920 · 1
R03$161,000 · 1
Top collaborators
- Jerry Edward Chipuk1 shared
- Meenhard Herlyn1 shared
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorInsightMutationMolecularSignal TransductionGenesLeadBaseMelanomaMalignant NeoplasmsPhenotypeSamplingPathway InteractionsNeoplasm MetastasisGeneticEventBiologicalIn VivoBraf GeneSignal PathwayOncogenicPlayFutureGenomics
Grant awards (19)
The Oncogene Activated Mitochondrial Unfolded Protein Response Regulates Senescence Biology$628,593
R01 · FY2023 · CA
Dissecting Phenotype Switching in Early Stage Melanomas$670,266
R01 · FY2022 · CA · contact PI
NOTCH inhibition in melanoma$184,331
R21 · FY2015 · CA · contact PI
NOTCH inhibition in melanoma$221,198
R21 · FY2014 · CA · contact PI
GAB2 in metastatic melanoma$320,691
R01 · FY2013 · CA · contact PI
Dissecting the Melanoma Genome$79,738
R21 · FY2013 · CA · contact PI
Dissecting the Melanoma Genome$63,964
R21 · FY2013 · CA · contact PI
GAB2 in metastatic melanoma$324,051
R01 · FY2012 · CA · contact PI
Dissecting the Melanoma Genome$223,208
R21 · FY2012 · CA · contact PI
GAB2 in metastatic melanoma$324,051
R01 · FY2011 · CA · contact PI
GAB2 in metastatic melanoma$333,954
R01 · FY2010 · CA · contact PI
GAB2 in metastatic melanoma$332,623
R01 · FY2009 · CA · contact PI
Functional analysis of the CYLD tumor suppressor$123,984
K08 · FY2009 · AR · contact PI
Molecular Basis for Spitzoid Tumors$80,500
R03 · FY2009 · CA · contact PI
Functional analysis of the CYLD tumor suppressor$123,984
K08 · FY2008 · AR · contact PI
Molecular Basis for Spitzoid Tumors$80,500
R03 · FY2008 · CA · contact PI
Functional analysis of the CYLD tumor suppressor$123,984
K08 · FY2007 · AR · contact PI
Functional analysis of the CYLD tumor suppressor$123,984
K08 · FY2006 · AR · contact PI
Functional analysis of the CYLD tumor suppressor$123,984
K08 · FY2005 · AR